HOUSE DOCKET, NO. 1199 FILED ON: 1/16/2013
HOUSE . . . . . . . . . . . . . . . No. 2065
|
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
Kathi-Anne Reinstein
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act relating to the dispensation of pharmaceuticals with an aesthetic purpose by physicians.
_______________
PETITION OF:
Name: | District/Address: | Date Added: |
Kathi-Anne Reinstein | 16th Suffolk | 1/16/2013 |
Michael D. Brady | 9th Plymouth |
|
HOUSE DOCKET, NO. 1199 FILED ON: 1/16/2013
HOUSE . . . . . . . . . . . . . . . No. 2065
By Ms. Reinstein of Revere, a petition (accompanied by bill, House, No. 2065) of Kathi-Anne Reinstein and Michael D. Brady relative to dispensing aesthetic pharmaceuticals. Public Health. |
The Commonwealth of Massachusetts
_______________
In the Year Two Thousand Thirteen
_______________
An Act relating to the dispensation of pharmaceuticals with an aesthetic purpose by physicians.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
Section 9. Section 9(b) of chapter 94C, as so appearing, is hereby amended by inserting after the paragraph that begins “For the purposes of this section, ’therapeutic contact lenses’” the following paragraphs:
Notwithstanding any other provision of law, a physician may, when acting in accordance with applicable federal law and any provision of this chapter which is consistent with federal law and in good faith and in the practice of medicine, dispense and sell aesthetic pharmaceuticals directly to patients in amounts greater than necessary for immediate and proper treatment. Prior to dispensing an aesthetic pharmaceutical to a patient, a physician must inform the patient of the option to fill the prescription for the aesthetic pharmaceutical at a pharmacy, if available. Physicians dispensing aesthetic pharmaceuticals must comply with all applicable state and federal labeling and recordkeeping requirement. Records maintained under this section must be accessible as provided under state and federal law. The department shall promulgate rules and regulation governing the dispensing and sale of aesthetic pharmaceuticals pursuant to this section.
For purposes of this section “aesthetic pharmaceutical” shall mean, (i) bimatoprost, hydroquinone, metronidazole, and tretinoin, or (ii) a prescription medication that (A) is classified by the department as a schedule VI controlled substance; (B) has been registered with or approved by the federal Food and Drug Administration; and (C) is prescribed for the skin, the treatment of certain skin conditions, or the enhancement of a patient’s appearance.